Neumora Therapeutics, Inc. Common Stock (NMRA) NASDAQ
$11.40 0.11 (0.97%)
Market Cap: $1.82B
As of 09/11/24 04:00 PM EDT. Market closed.
Neumora Therapeutics, Inc. Common Stock (NMRA)
NASDAQ
$11.40
0.11 (0.97%)
Market Cap: $1.82B
As of 09/11/24 04:00 PM EDT. Market closed.
Add to Portfolio
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Henry O. Gosebruch
Full Time Employees
108
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Henry O. Gosebruch
Full Time Employees
108
Address
490 Arsenal Way, Watertown, 02472.
PRICE CHART FOR NEUMORA THERAPEUTICS, INC. COMMON STOCK
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$11.50
Previous Close
$11.29
Days Range
$11.03 - $11.50
52 week range
$8.33 - $21
Volume
492,454
Avg. Volume (30 days)
800,891
Market Cap
$1.82B
Dividend Yield
-
P/E
(6.63)
Shares Outstanding
160,027,740
Open
$11.50
Previous Close
$11.29
Days Range
$11.03 - $11.50
52 week range
$8.33 - $21
Volume
492,454
Avg. Volume (30 days)
800,891
Market Cap
$1.82B
Dividend Yield
-
P/E
(6.63)
Shares Outstanding
160,027,740
FINANCIAL STATEMENTS FOR NEUMORA THERAPEUTICS, INC. COMMON STOCK
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NEUMORA THERAPEUTICS, INC. COMMON STOCK
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Pinto Joshua | Chief Financial Officer | Aug 27, 2024 | Sale | $11.39 | 15,693 | 178,806 | 138,965 | Aug 27, 2024, 05:58 PM |
| Pinto Joshua | Chief Financial Officer | Aug 26, 2024 | Sale | $11.78 | 31,642 | 372,588 | 154,658 | Aug 26, 2024, 06:17 PM |
| Pinto Joshua | Chief Financial Officer | Aug 23, 2024 | Sale | $11.59 | 24,169 | 280,005 | 186,300 | Aug 26, 2024, 06:17 PM |
| Pinto Joshua | Chief Financial Officer | Aug 22, 2024 | Sale | $11.63 | 28,496 | 331,468 | 210,469 | Aug 26, 2024, 06:17 PM |
| Burow Kristina | Director | Nov 14, 2023 | Buy | $11.98 | 3,357 | 40,217 | 4,131,207 | Nov 15, 2023, 06:55 PM |
| Burow Kristina | Director | Nov 13, 2023 | Buy | $11.75 | 31,653 | 371,923 | 4,127,850 | Nov 15, 2023, 06:55 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 14, 2023 | Buy | $11.98 | 3,357 | 40,217 | 4,131,207 | Nov 15, 2023, 06:54 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 13, 2023 | Buy | $11.75 | 31,653 | 371,923 | 4,127,850 | Nov 15, 2023, 06:54 PM |
| Burow Kristina | Director | Nov 10, 2023 | Buy | $11.49 | 17,275 | 198,481 | 4,096,197 | Nov 13, 2023, 07:01 PM |
| Burow Kristina | Director | Nov 09, 2023 | Buy | $10.53 | 31,079 | 327,262 | 4,078,922 | Nov 13, 2023, 07:01 PM |
| Burow Kristina | Director | Nov 08, 2023 | Buy | $11.03 | 92,251 | 1,017,821 | 4,047,843 | Nov 13, 2023, 07:01 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 10, 2023 | Buy | $11.49 | 17,275 | 198,481 | 4,096,197 | Nov 13, 2023, 07:00 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 09, 2023 | Buy | $10.53 | 31,079 | 327,262 | 4,078,922 | Nov 13, 2023, 07:00 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 08, 2023 | Buy | $11.03 | 92,251 | 1,017,821 | 4,047,843 | Nov 13, 2023, 07:00 PM |
| Burow Kristina | Director | Nov 07, 2023 | Buy | $11.50 | 30,192 | 347,208 | 3,955,592 | Nov 07, 2023, 07:00 PM |
| Burow Kristina | Director | Nov 06, 2023 | Buy | $11.55 | 43,082 | 497,597 | 3,925,400 | Nov 07, 2023, 07:00 PM |
| Burow Kristina | Director | Nov 03, 2023 | Buy | $11.38 | 22,420 | 255,140 | 3,882,318 | Nov 07, 2023, 07:00 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 07, 2023 | Buy | $11.50 | 30,192 | 347,208 | 3,955,592 | Nov 07, 2023, 06:59 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 06, 2023 | Buy | $11.55 | 43,082 | 497,597 | 3,925,400 | Nov 07, 2023, 06:59 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Nov 03, 2023 | Buy | $11.38 | 22,420 | 255,140 | 3,882,318 | Nov 07, 2023, 06:59 PM |
| Burow Kristina | Director | Sep 28, 2023 | Buy | $13.44 | 41,951 | 563,699 | 3,825,338 | Sep 29, 2023, 06:55 PM |
| Burow Kristina | Director | Sep 29, 2023 | Buy | $13.98 | 34,560 | 483,149 | 3,859,898 | Sep 29, 2023, 06:55 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Sep 29, 2023 | Buy | $13.98 | 34,560 | 483,149 | 3,859,898 | Sep 29, 2023, 06:53 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Sep 28, 2023 | Buy | $13.44 | 41,951 | 563,699 | 3,825,338 | Sep 29, 2023, 06:53 PM |
| Burow Kristina | Director | Sep 26, 2023 | Buy | $11.73 | 34,000 | 398,820 | 3,758,883 | Sep 27, 2023, 08:19 PM |
| Burow Kristina | Director | Sep 27, 2023 | Buy | $12.31 | 24,504 | 301,644 | 3,783,387 | Sep 27, 2023, 08:19 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Sep 27, 2023 | Buy | $12.31 | 24,504 | 301,644 | 3,783,387 | Sep 27, 2023, 08:18 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Sep 26, 2023 | Buy | $11.73 | 34,000 | 398,820 | 3,758,883 | Sep 27, 2023, 08:18 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Sep 25, 2023 | Buy | $11.22 | 60,740 | 681,464 | 3,724,883 | Sep 25, 2023, 09:38 PM |
| ARCH Venture Partners XII, LLC | 10% Owner | Sep 22, 2023 | Buy | $11.14 | 40,000 | 445,600 | 3,664,143 | Sep 25, 2023, 09:38 PM |
| Burow Kristina | Director | Sep 25, 2023 | Buy | $11.22 | 60,740 | 681,464 | 3,724,883 | Sep 25, 2023, 09:37 PM |
| Burow Kristina | Director | Sep 22, 2023 | Buy | $11.14 | 40,000 | 445,600 | 3,664,143 | Sep 25, 2023, 09:37 PM |
| Burow Kristina | Director | Sep 19, 2023 | Buy | $17.00 | 1,500,000 | 25,500,000 | 3,624,143 | Sep 20, 2023, 06:23 AM |
| ARCH Venture Partners X, LLC | 10% Owner | Sep 19, 2023 | Buy | $17.00 | 1,500,000 | 25,500,000 | 3,624,143 | Sep 20, 2023, 06:16 AM |
| ARCH Venture Partners X, LLC | 10% Owner | Sep 19, 2023 | Buy | $17.00 | 1,500,000 | 25,500,000 | 3,624,143 | Sep 20, 2023, 06:15 AM |
| Gosebruch Henry O | President & CEO | Sep 19, 2023 | Buy | $12.62 | 15,000 | 189,370 | 15,000 | Sep 19, 2023, 09:47 PM |
| AMGEN INC | 10% Owner | Sep 19, 2023 | Buy | $17.00 | 1,764,705 | 29,999,985 | 35,368,653 | Sep 19, 2023, 07:52 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN NEUMORA THERAPEUTICS, INC. COMMON STOCK
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 4,603,394 | 0.00102% | 367.08% | Other |
| ICONIQ CAPITAL, LLC | 3,398,628 | 0.72% | No change | Growth |
| ORBIMED ADVISORS LLC | 1,500,000 | 0.29% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,285,462 | 0.00111% | 184.15% | Other |
| BAKER BROS. ADVISORS LP | 1,034,600 | 0.13% | 63.22% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 380,160 | 0.00654% | -44.76% | Event Driven |
| RENAISSANCE TECHNOLOGIES LLC | 138,900 | 0.003% | Exited | Other |
| ALPS ADVISORS INC | 124,418 | 0.0084% | 15.51% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 65,728 | 0.11% | New | Event Driven |
BUYBACK ANNOUNCEMENT(S) FOR NEUMORA THERAPEUTICS, INC. COMMON STOCK
LOADING...